Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 4, Pages e60975
Publisher
Public Library of Science (PLoS)
Online
2013-04-13
DOI
10.1371/journal.pone.0060975
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast
- (2012) Sophie Doublier et al. BMC CANCER
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- Collateral sensitivity as a strategy against cancer multidrug resistance
- (2012) Kristen M. Pluchino et al. DRUG RESISTANCE UPDATES
- Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer
- (2011) Chiara Riganti et al. BIOCHEMICAL PHARMACOLOGY
- Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
- (2011) S. R. Mattarollo et al. CANCER RESEARCH
- Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside
- (2011) Barbara Castella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between V 9V 2 T Cells, CD8+ T Cells, Regulatory T Cells, and Dendritic Cells
- (2011) B. Castella et al. JOURNAL OF IMMUNOLOGY
- Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin
- (2011) Arti Shukla et al. Molecular Cancer
- Immune parameters affecting the efficacy of chemotherapeutic regimens
- (2011) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- Improved Clinical Outcome in Indolent B-Cell Lymphoma Patients Vaccinated with Autologous Tumor Cells Experiencing Immunogenic Death
- (2010) R. Zappasodi et al. CANCER RESEARCH
- Nitrogen-Containing Bisphosphonates and Cancer Immunotherapy
- (2010) P. Clezardin et al. CURRENT PHARMACEUTICAL DESIGN
- Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells
- (2010) Joanna Kopecka et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells
- (2010) Joanna Kopecka et al. JOURNAL OF CONTROLLED RELEASE
- Ras regulates interleukin-1β-induced HIF-1α transcriptional activity in glioblastoma
- (2010) Vivek Sharma et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Dysregulation of the mevalonate pathway promotes transformation
- (2010) J. W. Clendening et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells
- (2009) D. Turk et al. CANCER RESEARCH
- Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model
- (2009) Penelope D. Ottewell et al. INTERNATIONAL JOURNAL OF CANCER
- Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
- (2009) Marta Coscia et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
- (2009) Sara De Boo et al. Molecular Cancer
- P-Glycoprotein Acts as an Immunomodulator during Neuroinflammation
- (2009) Gijs Kooij et al. PLoS One
- Interaction of the P-Glycoprotein Multidrug Efflux Pump with Cholesterol: Effects on ATPase Activity, Drug Binding and Transport†
- (2008) Paul D. W. Eckford et al. BIOCHEMISTRY
- Regulation of HMG-CoA reductase expression by hypoxia
- (2008) Valentina Pallottini et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer
- (2008) P. D. Ottewell et al. JNCI-Journal of the National Cancer Institute
- Fasudil-induced hypoxia-inducible factor-1α degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells
- (2008) Keiko Takata et al. MOLECULAR CANCER THERAPEUTICS
- Immunogenicity of anthracyclines: moving towards more personalized medicine
- (2008) Lionel Apetoh et al. TRENDS IN MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started